Related Experiment Video
Updated: May 17, 2026

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
Published on: March 30, 2017
Developing and advancing dry powder inhalation towards enhanced therapeutics
S Stegemann1, S Kopp, G Borchard
1Capsugel, Bornem, Belgium. sven.stegemann@capsugel.com
Enhanced therapeutics offer innovation in drug delivery, particularly for respiratory diseases via pulmonary drug delivery systems. These advanced formulations improve patient outcomes and healthcare efficiency.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Respiratory Medicine
Background:
- Enhanced therapeutics, derived from generics, offer improved patient benefits and represent low-risk innovation.
- Pulmonary drug delivery is crucial for treating chronic respiratory diseases and delivering complex drugs unsuitable for oral administration.
- Dry powder inhalation systems aim for targeted deep lung delivery through optimized formulation, packaging, and device design.
Purpose of the Study:
- To review advancements in pulmonary drug delivery for enhanced therapeutics.
- To highlight the importance of formulation, packaging, and device in dry powder inhalation systems.
- To discuss methodologies for testing and regulatory pathways for orally inhaled products.
Main Methods:
- Review of existing literature on pulmonary drug delivery and enhanced therapeutics.
- Analysis of dry powder inhalation system components: formulation, primary packaging, and device.
- Examination of non-clinical and clinical performance testing methodologies.
Main Results:
- Pulmonary drug delivery is a key route for treating respiratory ailments and systemic delivery of complex drugs.
- Optimization of dry powder inhalation systems involves a multi-faceted approach.
- Established regulatory pathways exist for orally inhaled products.
Conclusions:
- Pulmonary drug delivery is a significant area for future innovation in treating lung diseases.
- Enhanced therapeutics via inhalation offer a promising avenue for improved patient care.
- Continued research is vital for optimizing drug delivery to the deep lung.
Related Concept Videos
Inhaled Medications
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral Drug Delivery Systems: Introduction
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

